Should You Hold Acurx Pharmaceuticals Inc (ACXP) in Biotechnology Industry?

A rating of 90 puts Acurx Pharmaceuticals Inc (ACXP) near the top of the Biotechnology industry according to InvestorsObserver. Acurx Pharmaceuticals Inc's score of 90 means it scores higher than 90% of stocks in the industry. Acurx Pharmaceuticals Inc also received an overall rating of 77, putting it above 77% of all stocks. Biotechnology is ranked 31 out of the 148 industries.

ACXP has an Overall Score of 77. Find out what this means to you and get the rest of the rankings on ACXP!

See Full ACXP Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 77 would rank higher than 77 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Acurx Pharmaceuticals Inc Stock Today?

Acurx Pharmaceuticals Inc (ACXP) stock has risen 3.87% while the S&P 500 is lower by -0.59% as of 12:55 PM on Thursday, Jan 19. ACXP is higher by $0.15 from the previous closing price of $3.88 on volume of 37,390 shares. Over the past year the S&P 500 has fallen -13.84% while ACXP is lower by -8.41%. ACXP lost -$1.09 per share the over the last 12 months. Click Here to get the full Stock Report for Acurx Pharmaceuticals Inc stock.